# Real-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLC

> **NCT04105153** · — · COMPLETED · sponsor: **Thoraxklinik-Heidelberg gGmbH** · enrollment: 400 (actual)

## Conditions studied

- EGFR Positive Non-small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04105153
- **Lead sponsor:** Thoraxklinik-Heidelberg gGmbH
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-15
- **Primary completion:** 2019-12-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2023-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04105153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04105153, "Real-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04105153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*